113 related articles for article (PubMed ID: 28832288)
1. Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial.
Venter WDF; Majam M; Akpomiemie G; Arulappan N; Moorhouse M; Mashabane N; Chersich MF
BMC Public Health; 2017 Jul; 17(Suppl 3):445. PubMed ID: 28832288
[TBL] [Abstract][Full Text] [Related]
2. Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
Myer L; Kamkuemah M; Kaplan R; Bekker LG
Trop Med Int Health; 2013 Nov; 18(11):1400-5. PubMed ID: 24102663
[TBL] [Abstract][Full Text] [Related]
3. The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative.
Diomandé FV; Bissagnéné E; Nkengasong JN; Maurice C; Monga B; Laga M; Nolan ML
AIDS; 2003 Jul; 17 Suppl 3():S87-93. PubMed ID: 14565614
[TBL] [Abstract][Full Text] [Related]
4. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
Kamkuemah M; Kaplan R; Bekker LG; Little F; Myer L
Trop Med Int Health; 2015 Apr; 20(4):518-26. PubMed ID: 25442109
[TBL] [Abstract][Full Text] [Related]
5. Screening HIV-infected adults in Malawi for anaemia: impact on eligibility for antiretroviral therapy.
Page ID; McKew SJ; Kudzala AG; Fullwood C; van Oosterhout JJ; Bates I
Int J STD AIDS; 2013 Jun; 24(6):449-53. PubMed ID: 23970747
[TBL] [Abstract][Full Text] [Related]
6. Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa.
Larson BA; Rockers PC; Bonawitz R; Sriruttan C; Glencross DK; Cassim N; Coetzee LM; Greene GS; Chiller TM; Vallabhaneni S; Long L; van Rensburg C; Govender NP
PLoS One; 2016; 11(7):e0158986. PubMed ID: 27390864
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
[TBL] [Abstract][Full Text] [Related]
8. Changes in viral hepatitis B screening practices over time in West African HIV clinics.
Coffie PA; Patassi A; Doumbia A; Bado G; Messou E; Minga A; Allah-Kouadio E; Zannou DM; Seydi M; Kakou AR; Dabis F; Wandeler G
Med Mal Infect; 2017 Oct; 47(6):394-400. PubMed ID: 28545675
[TBL] [Abstract][Full Text] [Related]
9. Changes in elevated cholesterol in the era of tenofovir in South Africa: risk factors, clinical management and outcomes.
Jamieson L; Evans D; Brennan AT; Moyo F; Spencer D; Mahomed K; Maskew M; Long L; Rosen S; Fox MP
HIV Med; 2017 Sep; 18(8):595-603. PubMed ID: 28332270
[TBL] [Abstract][Full Text] [Related]
10. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
[TBL] [Abstract][Full Text] [Related]
11. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.
Iwuji CC; Orne-Gliemann J; Larmarange J; Balestre E; Thiebaut R; Tanser F; Okesola N; Makowa T; Dreyer J; Herbst K; McGrath N; Bärnighausen T; Boyer S; De Oliveira T; Rekacewicz C; Bazin B; Newell ML; Pillay D; Dabis F;
Lancet HIV; 2018 Mar; 5(3):e116-e125. PubMed ID: 29199100
[TBL] [Abstract][Full Text] [Related]
12. Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa.
Kerkhoff AD; Wood R; Cobelens FG; Gupta-Wright A; Bekker LG; Lawn SD
BMC Infect Dis; 2014 Dec; 14():3860. PubMed ID: 25528467
[TBL] [Abstract][Full Text] [Related]
13. Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.
Cassim N; Schnippel K; Coetzee LM; Glencross DK
PLoS One; 2017; 12(2):e0171675. PubMed ID: 28166254
[TBL] [Abstract][Full Text] [Related]
14. Lamivudine plus tenofovir versus lamivudine plus adefovir for the treatment of hepatitis B virus in HIV-coinfected patients, starting antiretroviral therapy.
Sarkar J; Saha D; Bandyopadhyay B; Saha B; Chakravarty R; Guha SK
Indian J Med Microbiol; 2018; 36(2):217-223. PubMed ID: 30084414
[TBL] [Abstract][Full Text] [Related]
15. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
[TBL] [Abstract][Full Text] [Related]
16. Tenofovir-based antiretroviral therapy in
HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database.
Boettiger DC; Kerr S; Ditangco R; Chaiwarith R; Li PC; Merati TP; Pham TT; Kiertiburanakul S; Kumarasamy N; Vonthanak S; Lee CK; Van Kinh N; Pujari S; Wong WW; Kamarulzaman A; Zhang F; Yunihastuti E; Choi JY; Oka S; Ng OT; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Law M;
Antivir Ther; 2016; 21(1):27-35. PubMed ID: 26069150
[TBL] [Abstract][Full Text] [Related]
17. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
[TBL] [Abstract][Full Text] [Related]
18. Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
Archampong TN; Lartey M; Sagoe KW; Obo-Akwa A; Kenu E; Gillani FS; Yang H; Boamah I; Flanigan T; Kwara A
BMC Infect Dis; 2016 Jan; 16():14. PubMed ID: 26759172
[TBL] [Abstract][Full Text] [Related]
19. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
[TBL] [Abstract][Full Text] [Related]
20. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.
Boyd A; Bottero J; Miailhes P; Lascoux-Combe C; Rougier H; Girard PM; Serfaty L; Lacombe K
J Int AIDS Soc; 2017 Feb; 20(1):21426. PubMed ID: 28362068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
